Literature DB >> 15858813

Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.

Petra Nowotny1, Anthony L Hinrichs, Scott Smemo, John S K Kauwe, Taylor Maxwell, Peter Holmans, Marian Hamshere, Dragana Turic, Luke Jehu, Paul Hollingworth, Pamela Moore, Leslie Bryden, Amanda Myers, Lisa M Doil, Kristina M Tacey, Alison M Gibson, Ian G McKeith, Robert H Perry, Chris M Morris, Leon Thal, John C Morris, Michael C O'Donovan, Simon Lovestone, Andrew Grupe, John Hardy, Michael J Owen, Julie Williams, Alison Goate.   

Abstract

Linkage studies have suggested there is a susceptibility gene for late onset Alzheimer's disease (LOAD) in a broad region of chromosome 10. A strong positional and biological candidate is the gene encoding the insulin-degrading enzyme (IDE), a protease involved in the catabolism of Abeta. However, previous association studies have produced inconsistent results. To systematically evaluate the role of variation in IDE in the risk for LOAD, we genotyped 18 SNPs spanning a 276 kb region in and around IDE, including three "tagging" SNPs identified in an earlier study. We used four case-control series with a total of 1,217 cases and 1,257 controls. One SNP (IDE_7) showed association in two samples (P-value = 0.0066, and P = 0.026, respectively), but this result was not replicated in the other two series. None of the other SNPs showed association with LOAD in any of the tested samples. Haplotypes, constructed from the three tagging SNPs, showed no globally significant association. In the UK2 series, the CTA haplotype was over-represented in cases (P = 0.046), and in the combined data set, the CCG haplotype was more frequent in controls (P = 0.015). However, these weak associations observed in our series were in the opposite direction to the results in previous studies. Although our results are not universally negative, we were unable to replicate the results of previous studies and conclude that common variants or haplotypes of these variants in IDE are not major risk factors for LOAD. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858813     DOI: 10.1002/ajmg.b.30186

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

1.  Physiological effects of manipulating the level of insulin-degrading enzyme in insulin-producing cells of Drosophila.

Authors:  Joogyung Hyun; Carl Hashimoto
Journal:  Fly (Austin)       Date:  2011-01-01       Impact factor: 2.160

2.  Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.

Authors:  Nicole Schupf; Annie Lee; Naeun Park; Lam-Ha Dang; Deborah Pang; Alexander Yale; David Kyung-Taek Oh; Sharon J Krinsky-McHale; Edmund C Jenkins; José A Luchsinger; Warren B Zigman; Wayne Silverman; Benjamin Tycko; Sergey Kisselev; Lorraine Clark; Joseph H Lee
Journal:  Neurobiol Aging       Date:  2015-06-19       Impact factor: 4.673

Review 3.  All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.

Authors:  Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

4.  Phylogenetics applied to genotype/phenotype association and selection analyses with sequence data from angptl4 in humans.

Authors:  Taylor J Maxwell; Matthew L Bendall; Jeffrey Staples; Todd Jarvis; Keith A Crandall
Journal:  Int J Mol Sci       Date:  2010-01-25       Impact factor: 5.923

5.  HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.

Authors:  Sarah E Lloyd; Martin Rossor; Nick Fox; Simon Mead; John Collinge
Journal:  BMC Med Genet       Date:  2009-09-15       Impact factor: 2.103

6.  Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.

Authors:  Hui-Zhen Wang; Rui Bi; Deng-Feng Zhang; Guo-Dong Li; Xiao-Hong Ma; Yiru Fang; Tao Li; Chen Zhang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2015-09-11       Impact factor: 5.590

7.  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

Authors:  Andrew Grupe; Yonghong Li; Charles Rowland; Petra Nowotny; Anthony L Hinrichs; Scott Smemo; John S K Kauwe; Taylor J Maxwell; Sara Cherny; Lisa Doil; Kristina Tacey; Ryan van Luchene; Amanda Myers; Fabienne Wavrant-De Vrièze; Mona Kaleem; Paul Hollingworth; Luke Jehu; Catherine Foy; Nicola Archer; Gillian Hamilton; Peter Holmans; Chris M Morris; Joseph Catanese; John Sninsky; Thomas J White; John Powell; John Hardy; Michael O'Donovan; Simon Lovestone; Lesley Jones; John C Morris; Leon Thal; Michael Owen; Julie Williams; Alison Goate
Journal:  Am J Hum Genet       Date:  2005-11-15       Impact factor: 11.025

8.  Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging.

Authors:  Perry G Ridge; Taylor J Maxwell; Christopher D Corcoran; Maria C Norton; Joann T Tschanz; Elizabeth O'Brien; Richard A Kerber; Richard M Cawthon; Ronald G Munger; John S K Kauwe
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

9.  Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Olivia Belbin; Fanggeng Zou; Mariet Allen; Nilufer Ertekin-Taner; Morad Ansari; Samantha L Wilcox; Mariah R Kashino; Li Ma; Linda H Younkin; Samuel G Younkin; Curtis S Younkin; Toros A Dincman; Melissa E Howard; Chanley C Howell; Chloe M Stanton; Christopher M Watson; Michael Crump; Veronique Vitart; Caroline Hayward; Nicholas D Hastie; Igor Rudan; Harry Campbell; Ozren Polasek; Kristelle Brown; Peter Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Patrick G Kehoe; David M Mann; A David Smith; Helen Beaumont; Donald Warden; Clive Holmes; Reinhard Heun; Heike Kölsch; Noor Kalsheker; V Shane Pankratz; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Alan F Wright; Steven G Younkin; Kevin Morgan
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

10.  IDE Gene Polymorphism Influences on BPSD in Mild Dementia of Alzheimer's Type.

Authors:  Noriko Sato; Akinori Ueki; Hideo Ueno; Hidetaka Shinjo; Yoshio Morita
Journal:  Curr Gerontol Geriatr Res       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.